(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.08%.
Anixa Biosciences's earnings in 2026 is -$10,308,000.On average, 7 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,627,461, with the lowest ANIX earnings forecast at -$12,485,774, and the highest ANIX earnings forecast at -$8,449,020. On average, 6 Wall Street analysts forecast ANIX's earnings for 2027 to be -$11,627,461, with the lowest ANIX earnings forecast at -$12,814,347, and the highest ANIX earnings forecast at -$8,449,020.
In 2028, ANIX is forecast to generate -$11,627,461 in earnings, with the lowest earnings forecast at -$11,171,482 and the highest earnings forecast at -$11,969,445.